{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:55:00Z","timestamp":1781567700156,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013327","name":"Intercollegiate Center for Management Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010573","name":"Dioraphte Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.xagr.2026.100625","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:48:32Z","timestamp":1773852512000},"page":"100625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6065-0708","authenticated-orcid":false,"given":"Assefa","family":"Desalew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ellen","family":"van der Schoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiki N.","family":"Mjema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tienke","family":"Vermeiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Schonewille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremia J.","family":"Pyuza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse","family":"Gure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.T. (Joanne)","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abera Kenay","family":"Tura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2026.100625_bib0001","unstructured":"Antonette TD. Hemolytic Disease of the Fetus and Newborn - Women\u2019s Health Issues - MSD Manual Consumer Version 2024. Available from: https:\/\/www.https:\/\/www.msdmanuals.com\/professional\/searchresults?query=hemolytic+disease+of+the+fetus+and+newborn&icd9=773 Accessed Aug. 8, 2024]<\/bib>"},{"issue":"2","key":"10.1016\/j.xagr.2026.100625_bib0002","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ijgo.13459","article-title":"FIGO\/ICM guidelines for preventing Rhesus disease: a call to action","volume":"152","author":"Visser","year":"2021","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.xagr.2026.100625_bib0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"De Haas","year":"2015","journal-title":"Vox Sanguinis"},{"issue":"4","key":"10.1016\/j.xagr.2026.100625_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0000000000005709","article-title":"Management of red cell alloimmunization in pregnancy","volume":"144","author":"Moise","year":"2024","journal-title":"Obs Gynecol"},{"key":"10.1016\/j.xagr.2026.100625_bib0005","first-page":"491","article-title":"Hemolytic disease of the newborn: a review of current trends and prospects","volume":"12","author":"Myle","year":"2021","journal-title":"Pediatr Heal Med Ther"},{"issue":"7","key":"10.1016\/j.xagr.2026.100625_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0235807","article-title":"Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children","volume":"15","author":"Pegoraro","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xagr.2026.100625_bib0007","doi-asserted-by":"crossref","unstructured":"Zipursky A, Bhutani VK. Impact of Rhesus disease on the global problem of bilirubin-induced neurologic dysfunction. 2015; 20:2-5. doi: 10.1016\/j.siny.2014.12.001.","DOI":"10.1016\/j.siny.2014.12.001"},{"issue":"3","key":"10.1016\/j.xagr.2026.100625_bib0008","article-title":"Management of alloimmunization during pregnancy","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.xagr.2026.100625_bib0009","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2105\/AJPH.66.9.854","article-title":"Racial difference in incidence of ABO hemolytic disease","volume":"66","author":"Bucher","year":"1976","journal-title":"Am J Public Heal"},{"issue":"1","key":"10.1016\/j.xagr.2026.100625_bib0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2147\/IJWH.S15165","article-title":"Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-Rhd immunoglobulin and effective management of d-negative pregnancies","volume":"2","author":"Osaro","year":"2010","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.xagr.2026.100625_bib0011","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(23)01888-3","article-title":"Monoclonal RhD prophylaxis: high time to evaluate efficacy","volume":"403","author":"Verweij","year":"2024","journal-title":"Lancet"},{"issue":"SUPPL 1","key":"10.1016\/j.xagr.2026.100625_bib0012","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/pr.2013.208","article-title":"Neonatal hyperbilirubinemia and rhesus disease of the newborn: Incidence and impairment estimates for 2010 at regional and global levels","volume":"74","author":"Bhutani","year":"2013","journal-title":"Pediatr Res"},{"key":"10.1016\/j.xagr.2026.100625_bib0013","unstructured":"Ethiopian Ministry of Health. National antenatal care guidelines: ensuring positive pregnancy experience. Ethiopian Ministry of Health. Addis Ababa, Ethiopia; 2022. p. 1\u201368. Available from: https:\/\/www.moh.gov.et\/sites\/default\/files\/2024-07\/National.Antenatal.Care.Guideline_2022.pdf Accessed Aug. 2024]"},{"issue":"2","key":"10.1016\/j.xagr.2026.100625_bib0014","first-page":"1130","article-title":"Maternal alloantibodies and foetal complications in Jimma World Journal of Pharmaceutical Research","volume":"5","author":"Nair","year":"2016","journal-title":"World J Pharm Res."},{"issue":"7","key":"10.1016\/j.xagr.2026.100625_bib0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S2352-4642(18)30071-3","article-title":"Rhesus disease: a global prevention strategy","volume":"2","author":"Zipursky","year":"2018","journal-title":"Lancet Child Adolesc Heal"},{"key":"10.1016\/j.xagr.2026.100625_bib0016","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-22-00281","article-title":"Establishing the Ethiopian obstetric surveillance system for monitoring maternal outcomes in Eastern Ethiopia: a pilot study","volume":"11","author":"Tura","year":"2023","journal-title":"Glob Health Sci Pract"},{"issue":"3","key":"10.1016\/j.xagr.2026.100625_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053881","article-title":"Predictors of adverse perinatal outcome among women who gave birth at Medical Center of Southwest Ethiopia: a retrospective cohort study","volume":"12","author":"Jaleta","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.xagr.2026.100625_bib0018","doi-asserted-by":"crossref","first-page":"448","DOI":"10.5468\/ogs.20004","article-title":"Evaluation of maternal rhesus blood type as a risk factor in adverse pregnancy outcomes in Korea: a nationwide health insurance database study","volume":"63","author":"Jin","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.xagr.2026.100625_bib0019","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2147\/JBM.S440952","article-title":"Magnitude of red blood cell alloimmunization among pregnant women attending antenatal care at Wolaita Sodo University Comprehensive Specialized Hospital, Southwest Ethiopia","volume":"14","author":"Kebamo","year":"2023","journal-title":"J Blood Med"},{"issue":"12","key":"10.1016\/j.xagr.2026.100625_bib0020","first-page":"892","article-title":"Frequency of ABO and Rh (D) Blood Groups and hemoglobin threshold among pregnant women in Family Guidance Association, Mekelle Model Clinic, North Ethiopia","volume":"5","author":"Alemu","year":"2014","journal-title":"Int J Pharma Sci Res"},{"key":"10.1016\/j.xagr.2026.100625_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2023.1167736","article-title":"Prevalence and determinants of RH alloimmunization in Rh-negative women in teaching hospitals of Addis Ababa, Ethiopia: a hospital-based cross-sectional study","volume":"4","author":"Maruta","year":"2023","journal-title":"Front Glob Women\u2019s Health"},{"key":"10.1016\/j.xagr.2026.100625_bib0022","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/vox.13376","article-title":"A cross-sectional study of haemolytic disease of the newborn in Uganda","volume":"117","author":"Dhabangi","year":"2022","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.xagr.2026.100625_bib0023","first-page":"57","article-title":"Clinical Management Guidelines for Obstetricians \u2013 Prevention of Rh D Alloimmunization","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xagr.2026.100625_bib0024","unstructured":"Walker WC Haemolytic Disease of the Newborn in Recent Advances in Paediatrics, 4th edn. London, UK: J.A. Churchill.; 1970."},{"key":"10.1016\/j.xagr.2026.100625_bib0025","first-page":"1","article-title":"Fucosylation limits ADCC in clinically used anti-RhD monoclonal antibodies","author":"Koike","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.xagr.2026.100625_bib0026","doi-asserted-by":"crossref","unstructured":"Contreras M, Kumpel B, Olovnikova N. Anti-D prophylaxis should protect all newborns from haemolytic disease, regardless of their country of residence Vox Sang. 2024; 119:1221-2. doi: 10.1111\/vox.13745.","DOI":"10.1111\/vox.13745"},{"key":"10.1016\/j.xagr.2026.100625_bib0027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/IJWH.S402373","article-title":"Perinatal Outcome of pregnant women with RhD sensitization: a five-year cross-sectional study at a tertiary care hospital in Ethiopia","author":"Kureba","year":"2023","journal-title":"Int J Women\u2019s Health"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577826000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577826000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:30:32Z","timestamp":1781566232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577826000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2666577826000237"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2026.100625","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2026.100625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100625"}}